Synopsys, Inc. $SNPS Holdings Reduced by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC reduced its stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 11.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,751 shares of the semiconductor company’s stock after selling 2,869 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Synopsys were worth $10,687,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in SNPS. Vanguard Group Inc. lifted its stake in shares of Synopsys by 20.7% in the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after acquiring an additional 3,120,401 shares during the period. Victory Capital Management Inc. lifted its stake in shares of Synopsys by 238.8% in the 3rd quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock worth $1,393,506,000 after acquiring an additional 1,990,608 shares during the period. Coatue Management LLC acquired a new stake in shares of Synopsys in the 3rd quarter worth approximately $892,605,000. Capital Research Global Investors lifted its stake in shares of Synopsys by 226.6% in the 3rd quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock worth $1,245,533,000 after acquiring an additional 1,751,432 shares during the period. Finally, Norges Bank acquired a new stake in shares of Synopsys in the 4th quarter worth approximately $730,197,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SNPS has been the subject of a number of research analyst reports. Bank of America upped their price target on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. The Goldman Sachs Group set a $600.00 price target on shares of Synopsys and gave the stock a “buy” rating in a research note on Wednesday, February 25th. Piper Sandler upped their price target on shares of Synopsys from $430.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday, May 28th. BNP Paribas Exane upped their price target on shares of Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Finally, HSBC lowered shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a research note on Friday, February 20th. Nine investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Synopsys currently has an average rating of “Hold” and a consensus target price of $563.81.

Read Our Latest Report on Synopsys

Synopsys Stock Up 0.1%

SNPS stock opened at $454.38 on Tuesday. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73. The firm has a market cap of $87.00 billion, a PE ratio of 105.18, a P/E/G ratio of 2.67 and a beta of 1.22. The firm has a 50 day simple moving average of $474.73 and a 200 day simple moving average of $461.19. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the previous year, the business earned $3.67 earnings per share. The firm’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.56% of the company’s stock.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.